πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 225 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7825154

Small molecule inhibitors of botulinum neurotoxins

The United States of America as represented by the Secretary of the Army Β· Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7790182

Protein vaccines against poxviruses

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7790181

Live attenuated viral vaccines for Eastern Equine Encephalitis virus

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7790186

Plasmodium vivax hybrid circumsporozoite protein and vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7786285

Recombinant vaccine against botulinum neurotoxin

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7780966

Artificial invaplex

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7759106

Construction of live attenuated Shigella vaccine strains that express CFA/I antigens (CfaB

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7754461

Large-scale production of human serum butyrylcholinesterase as a bioscavenger

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jul 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7741431

Liposomes containing novel targeting and/or fusogenic peptides, preparations containing th

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jun 22 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7736656

Immunogenic compositions and vaccines for Ebola

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jun 15 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7731975

Chimeric filovirus glycoprotein

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7722889

Plasmodium liver stage antigens

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7718779

Prophylactic and therapeutic monoclonal antibodies

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7682618

Generation of virus-like particles and use as panfilovirus vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7678828

Methods for the formulation and manufacture of artesunic acid for injection

The United States of America as represented by the Secretary of the Army Β· Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7666404

Glanders/meliodosis vaccines

The United States of America as represented by the Secretary of the Army Β· Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7662568

Immunoliposome-nucleic acid amplification (ILNAA) assay

The United States of America as represented by the Secretary of the Army Β· Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7638333

Anthrax vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7632659

Use of Shigella invaplex to transport functional proteins and transcriptionally active nuc

The United States of America as represented by the Secretary of the Army Β· Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7625571

Transformed bacteria producing CS6 antigens as vaccines

The United States of America as represented by the Secretary of the Army Β· Granted Tue Dec 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7604811

Oral-intestinal vaccines against diseases caused by enteropathic organisms using antigens

The United States of America as represented by the Secretary of the Army Β· Granted Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7595191

Isolation and purification of P. falciparum merozoite protein-142 vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7582680

Methods and compositions for treating mammalian spinal cord injuries

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7582430

Immunoliposome-nucleic acid amplification (ILNAA) assay

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted